As of 2024-12-15, the Fair Value of Abivax SA (ABVX.PA) is -14.00 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.14 EUR, the upside of Abivax SA is -296.13%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -30.63 | -37.55 | -41.36 | -69.90 | -147.74 | -65.44 |
| YoY growth | -93.60% | -22.58% | -10.14% | -69.02% | -111.36% | -61.34% |
| Market Cap (mil) | 452.32 |
| P/E | |
| Forward P/E |
| EPS | -2.80 |
| Avg earnings growth rate | -61.34% |
| TTM earnings | -177.43 |